Our data demonstrate that miR-671-5p specifically targets the 3′UTR of FOXM1 at 828–848 nt in all 21T cell lines, suggesting that miR-671-5p targets FOXM1 in all stages during BC transition. Here, FOXM1 is linked to breast cancer.